Klaviyo bumps up share pricing ahead of market debut
<img width="250" height="167" src="https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-250×167.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" decoding="async" style="float: left; margin-right: 5px;" link_thumbnail="" srcset="https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-250×167.jpg 250w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-700×467.jpg 700w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-768×512.jpg 768w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-120×80.jpg 120w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-245×163.jpg 245w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039-500×334.jpg 500w, https://www.leaprate.com/wp-content/uploads/2023/09/FIN-LP-Klaviyo-bumps-up-share-pricing-ahead-of-market-debut-5183635694iStock-1294491039.jpg 1253w" sizes="(max-width: 250px) 100vw, 250px" /><p><span data-contrast="auto">The company plans to list approximately 19.2 million shares for between $27 and $29 each, a $2 raise from its earlier indication of between $25 and $27. Nearly 20 times oversubscribed on the back of investor interest, experts are predicting a strong start on the New York Stock Exchange (NYSE).</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
<p><span data-contrast="auto">The positive response to the<a href="https://www.leaprate.com/news/arm-ipo-splash-largest-in-two-years/" target="_blank" rel="noopener"> Arm IPO</a> on the Nasdaq raised hopes that this heralds a revival in the typical IPO slump of the past few years. However, the less-than-enthusiastic reception of the Neumora Therapeutics debut put a slight damper on the excitement.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
<hr />
<p><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"><a href="https://finaffiliates.us20.list-manage.com/subscribe/post?u=e0dd4d77c259eb270712a4eeb&id=fd200b8f75&v_id=4291&f_id=00946ce6f0" target="_blank" rel="noopener noreferrer"><em>Don’t miss out the latest news, subscribe to LeapRate’s newsletter</em></a> </span></p>
<hr />
<p><span data-contrast="auto">Klaviyo decided to raise its pricing after Instacart, another IPO competitor, bumped up its price range on Friday. Notably, Softbank, the Arm parent company, did not increase its IPO pricing prior to the launch as it followed advisor suggestions to forgo the $1 per share increase, despite it equalling roughly $1bn. </span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
<p><span data-contrast="auto">September has been kind to US-based IPOs so far, and on average, they made more than $5bn, according to Dealogic statistics. Analysts are holding their breath for another impactful launch. BlackRock manages the Klaviyo assets, and AllianceBernstein hinted at buying up to $100m in shares.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
<p>The post <a rel="nofollow" href="https://www.leaprate.com/news/klaviyo-bumps-up-share-pricing-ahead-of-market-debut/">Klaviyo bumps up share pricing ahead of market debut</a> appeared first on <a rel="nofollow" href="https://www.leaprate.com">LeapRate</a>.</p>
Leave a Comment